Phathom Pharmaceuticals, Inc.PHATNASDAQ
Loading
Interest Expense Over TimeExpanding
Percentile Rank100
3Y CAGR+84.5%
5Y CAGR+106.4%
Studio
Year-over-Year Change

Interest expense on outstanding debt

3Y CAGR
+84.5%/yr
vs +577.0%/yr prior
5Y CAGR
+106.4%/yr
Recent deceleration
Acceleration
-492.5pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
37.4x
Strong expansion
Streak
7 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$171.51M+138.2%
2024$72.01M+71.6%
2023$41.97M+53.7%
2022$27.30M+302.3%
2021$6.79M+48.2%
2020$4.58M+9.7%
2019$4.18M+32030.8%
2018$13000.00-